PDC*line Pharma nets $4.24 mln
PDC*line Pharma, a Grenoble, France-based developer of a new immuno-oncology platform, has raised $4.24 million in funding. The investors included Meusinvest, Spinventure and Financière Spin-off Luxembourgeoise/INVESTSUD Group. The company has also named Eric Halioua as president and CEO.
6 December 2016•6 mins read
